Johnson & Johnson (JNJ) Receivables - Net (2009 - 2026)

Johnson & Johnson (JNJ) posted Receivables - Net of $17.7 billion for Q1 2026, up 3.16% sequentially from $17.2 billion in Q4 2025, and up 10.62% YoY from $16.0 billion in Q1 2025.

Johnson & Johnson (JNJ) Receivables - Net (2009 - 2026) Analysis & Trends

Johnson & Johnson (JNJ) has 18 years of Receivables - Net data on file, last reported at $17.7 billion in Q1 2026.

  • Quarterly Receivables - Net rose 10.62% year-over-year to $17.7 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $17.7 billion (up 10.62% YoY) and the FY2025 annual result came in at $17.2 billion, up 15.74% from the prior year.
  • Receivables - Net grew to $17.7 billion in Q1 2026 per JNJ's latest filing, from $17.2 billion in the prior quarter.
  • The five-year high for Receivables - Net was $17.8 billion in Q2 2025, with the low at $14.0 billion in Q1 2023.
  • Average Receivables - Net over 5 years is $16.0 billion, with a median of $16.0 billion recorded in 2022.
  • Year-over-year, Receivables - Net declined 8.59% in 2024 and rose 15.74% in 2025.
  • Johnson & Johnson's Receivables - Net stood at $15.9 billion in 2022, then declined by 6.4% to $14.9 billion in 2023, then slipped by 0.21% to $14.8 billion in 2024, then gained by 15.74% to $17.2 billion in 2025, then grew by 3.16% to $17.7 billion in 2026.
  • Business Quant data shows JNJ's Receivables - Net at $17.7 billion in Q1 2026, $17.2 billion in Q4 2025, and $17.6 billion in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn -
10 Biogen 30.87 Bn 26.59 Bn 1.82 Bn

Historic Data

Download Data
DateValue
Mar 29, 2026 17.72 Bn
Mar 29, 2026 17.72 Bn
Dec 28, 2025 17.18 Bn
Dec 28, 2025 17.18 Bn
Sep 28, 2025 17.61 Bn
Sep 28, 2025 17.61 Bn
Jun 29, 2025 17.85 Bn
Jun 29, 2025 17.85 Bn
Mar 30, 2025 16.02 Bn
Mar 30, 2025 16.02 Bn
Dec 29, 2024 14.84 Bn
Dec 29, 2024 14.84 Bn
Sep 29, 2024 16.17 Bn
Sep 29, 2024 16.17 Bn
Jun 30, 2024 15.79 Bn
Jun 30, 2024 15.79 Bn
Mar 31, 2024 14.95 Bn
Mar 31, 2024 14.95 Bn
Dec 31, 2023 14.87 Bn
Dec 31, 2023 14.87 Bn